GX BIO LABS · Product artwork

Blends

CJC-1295 No DAC + Ipamorelin

This listing combines CJC-1295 No DAC and ipamorelin at a stated 5 mg + 5 mg. The linked research concerns an individual component and does not test or validate the combined blend.

Select strength

5 mg + 5 mg

₹4,2001 vial

10 available

View COA for 5 mg + 5 mg

1 batch report available

Blend composition

CJC-1295 No DAC: 5 mg
Ipamorelin: 5 mg
Total labelled content: 10 mg

Supplied formula · See the batch COA for measured results.

Identity & specification

Catalogue composition: CJC-1295 No DAC 5 mg + ipamorelin 5 mg. These are supplied listing quantities, not independently verified assay results.

Laboratory research only

Not for human or veterinary administration. Listed strength is a supplied specification; see the matching batch report for measured results.

Batch documentation

1 report is available for this strength. Match the batch number on your supplied material.

View available COAs

UNDERSTAND THE COMPOUND

What is CJC-1295 No DAC + Ipamorelin?

The catalogue identifies two components: CJC-1295 No DAC and ipamorelin. Their stated quantities describe the listing, while each component's identity and the finished blend require separate documentation. The linked ipamorelin paper examines secretagogue pharmacology in experimental systems; it is not a study of this mixture. Human papers about long-acting, albumin-binding CJC-1295 also cannot be treated as evidence for the no-DAC component. Combining names from the literature does not establish a combined response, compatibility or stability. No verified study of this exact formulation and ratio is linked here, so blend-specific performance remains unestablished.

Research context

Component context: ipamorelin pharmacology
Exact blend: direct evidence not established

Batch specification

Catalogue composition: CJC-1295 No DAC 5 mg + ipamorelin 5 mg. These are supplied listing quantities, not independently verified assay results.

EXPLORE THE EVIDENCE

Studies & research references

These papers concern individual ingredients, not the finished blend. Each source identifies what was studied and the limits of its findings. Published research is separate from this product’s batch COA.

Component only · Laboratory and animal study

Ipamorelin secretagogue pharmacology · 1998

This study examined ipamorelin in cell and animal models. It supplies context for one named component only; the combined CJC-1295 No DAC + ipamorelin blend was not investigated.

Read study

Documentation & selection

Which strengths are listed for CJC-1295 No DAC + Ipamorelin?

CJC-1295 No DAC + Ipamorelin is currently listed in 5 mg + 5 mg. Select a strength above to see its price, product image and current stock. Listed quantities are supplied specifications, not measured batch results.

Is a COA available for CJC-1295 No DAC + Ipamorelin?

1 laboratory report is published for this compound. Match the selected strength and available batch identifiers, and open the original document to check the actual test scope.

Check this compound’s reports How to verify a COA

What is in CJC-1295 No DAC + Ipamorelin?

The supplied formula is 5 mg CJC-1295 No DAC + 5 mg Ipamorelin, totalling 10 mg. Ingredient studies do not establish the finished blend’s results. Check the original report for measured identity and quantities.

Understand research evidence

Explore blends Research & documentation Storage & handling Shipping Returns & refunds

Back to selection Back to all compounds